StonvexLoading…
StonvexStonvexStonvexCore line items from TRV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $11.92B | $48.83B | $36.40B | $23.93B |
Operating Income | $2.12B | $7.80B | $4.69B | $2.35B |
Net Income | $1.71B | $6.29B | $3.79B | $1.90B |
EPS (Diluted) | $7.78 | $27.43 | $16.45 | $8.23 |
Total Assets | $142.31B | $143.71B | $143.68B | $138.87B |
Total Liabilities | $110.32B | $110.81B | $112.07B | $109.36B |
Cash & Equivalents | $615.00M | $842.00M | $729.00M | $659.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 212.60M | 217.50M | 223.00M | 225.10M |